European Case Law Identifier: | ECLI:EP:BA:2018:T160813.20180508 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 08 May 2018 | ||||||||
Case number: | T 1608/13 | ||||||||
Application number: | 03781225.2 | ||||||||
IPC class: | A61M 1/16 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | D | ||||||||
Download and more information: |
|
||||||||
Title of application: | PERM SELECTIVE ASYMMETRIC HOLLOW FIBRE MEMBRANE FOR THE SEPARATION OF TOXIC MEDIATORS FROM BLOOD | ||||||||
Applicant name: | Gambro Lundia AB | ||||||||
Opponent name: | Fresenius Medical Care Deutschland GmbH | ||||||||
Board: | 3.2.02 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Sufficiency of disclosure - relationship between Article 83 and Article 84 Grounds for opposition - lack of clarity no ground for opposition - insufficiency of disclosure (no) Appeal decision - remittal to the department of first instance (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t131608eu1.html
Date retrieved: 17 May 2021